Skip to main content

Affiliate Newsletter: June 2025

Chelsea J avatar
Written by Chelsea J
Updated yesterday

This edition includes information about spirometry compliance, capability

and equipment

Important Reminder: Spirometry Compliance

We’ve recently observed a rise in cases where post-bronchodilator (post-BD) spirometry is not being performed, despite being clinically indicated during initial (pre-BD) spirometry testing.

As a reminder, post-bronchodilator spirometry must be performed on the same day, even if not pre-booked, when any one of the following apply:

  • FVC is < LLN, or

  • FEV1 is < LLN, or

  • FEV1/FVC is < LLN

This requirement is outlined in the Thoracic Society of Australia and New Zealand (TSANZ) and Australian & New Zealand Society of Respiratory Science (ANZSRS) 2024, which you can review here


🫁 Why This Matters

Performing both pre- and post-BD spirometry when clinically indicated is essential to assess for reversibility of airflow limitation, which helps differentiate between asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Failure to conduct post-BD testing when clinically indicated can lead to:

  • Incomplete assessments

  • Delayed or inaccurate diagnosis

  • Potential risk in clearance decisions for workplace health

Please ensure your clinicians are aware of this requirement and that your practice is equipped to complete pre/post Ventolin spirometry when necessary.

🩺 Need Help with Spirometry Equipment or Capabilities?

If your practice is currently unable to provide post-bronchodilator testing, or you have questions about spirometry interpretation, please contact our Affiliate Relationships team:
📧 affiliaterelationship@kinnect.com.au

We’re also here to assist with sourcing equipment and consumables. You can find approved products via our online store:
🛒 KINNECT Training Shop – Spirometry Products

✅ Additional Clinical Notes

  • Ensure bronchodilator administration aligns with recommended agents (e.g. salbutamol 400 mcg via spacer).

  • Wait time between bronchodilator administration and repeat testing should be 10–15 minutes, as per TSANZ guidelines.

  • Results should meet acceptability and repeatability criteria (Grade A–C) for interpretation.

  • Document if post-BD is clinically indicated but not performed, and record the reason (e.g. equipment unavailable, client declined, etc.).

Did this answer your question?